Experimental study of consumer responses to different sources of information about prescription drugs

被引:0
|
作者
Byl, Jacob P. [1 ]
Viscusi, W. Kip [2 ]
机构
[1] Western Kentucky Univ, Bowling Green, KY 42101 USA
[2] Univ Distinguished Prof Law, Econ & Management Vanderbilt Law Sch, 131 21st Ave, Nashville, TN 37203 USA
关键词
Risk updating; Experimental; Bayesian learning; Attorney advertising; Litigation advertising; Direct-to-consumer advertising; Prescription drugs; WILLINGNESS-TO-PAY; RISK; BEHAVIOR; DECISIONS; HEALTH; IMPACT;
D O I
10.1016/j.jebo.2020.10.025
中图分类号
F [经济];
学科分类号
02 ;
摘要
Consumers receive risk information about prescription drugs from many sources, including from largely unregulated attorney advertisements. This experiment measures subjective risk beliefs about prescription drugs and subjects' drug-taking behavior in an incentivized setting. Results of the experiment are used to estimate a Bayesian learning model to ascertain the risk levels implied by different information sources and the informational weights subjects place on these sources. Even after people have received scientifically based drug risk information from a doctor and product label, attorney litigation advertising boosts risk beliefs about side effects by an average of 16 out of 100 cases, which is roughly a 50% increase over baseline risk beliefs. Risk beliefs have a significant effect on drug-taking behavior in an incentivized environment. Experience with taking the drug also feeds back into the learning process about risk beliefs. Our experimental results help formalize how consumers update risk beliefs and suggest ways to encourage a learning environment that avoids alarmist updating based on information sources like attorney advertising. (c) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页码:754 / 771
页数:18
相关论文
共 50 条
  • [41] SOURCES OF INFORMATION ABOUT NEW DRUGS AND ATTITUDES TOWARDS DRUG PRESCRIBING - AN INTERNATIONAL STUDY OF DIFFERENCES BETWEEN PRIMARY CARE PHYSICIANS
    HULL, FM
    MARSHALL, T
    FAMILY PRACTICE, 1987, 4 (02) : 123 - 128
  • [42] Pilot study about the use of mobile apps as nutritional information for the food consumer
    Gomez, Alejandra
    Mesias, Marta
    REVISTA ESPANOLA DE COMUNICACION EN SALUD, 2021, 12 (02): : 206 - 214
  • [43] Consumer Learning from Own Experience and Social Information: An Experimental Study
    Davis, Andrew M.
    Gaur, Vishal
    Kim, Dayoung
    MANAGEMENT SCIENCE, 2021, 67 (05) : 2924 - 2943
  • [44] Pilot study about prescription in exceptional situations. Use of drugs for human in veterinary medicine
    Lobo, M.
    Diaz, Ma J.
    Garcia, J.
    Frejo, Ma T.
    CLINICA VETERINARIA DE PEQUENOS ANIMALES, 2011, 31 (03): : 143 - 149
  • [45] Wide variation in the number of different drugs prescribed by general practitioners - A prescription database study
    Bjerrum, L
    Bergman, U
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2000, 18 (02) : 94 - 98
  • [46] Case study: Development of and stakeholder responses to a nursing home consumer information system
    O'Meara, J
    Kitchener, M
    Collier, E
    Lyons, M
    de Billwiller-Kiss, A
    Simon, LP
    Harrington, C
    AMERICAN JOURNAL OF MEDICAL QUALITY, 2005, 20 (01) : 40 - 50
  • [47] Consumer-awareness and information sources on food safety A case study of Eastern Turkey
    Koc, Besir
    Ceylan, Melike
    NUTRITION & FOOD SCIENCE, 2009, 39 (06): : 643 - 654
  • [48] Determinants of Intention to Purchase Chicken in Italy: The Role of Consumer Risk Perception and Trust in Different Information Sources
    Stefani, Gianluca
    Cavicchi, Alessio
    Romano, Donato
    Lobb, Alexandra E.
    AGRIBUSINESS, 2008, 24 (04) : 523 - 537
  • [49] Experimental Study about Effect of Thermal Information Presentation to Mouse
    Iizuka, Shigeyoshi
    Yamamoto, Sakae
    HUMAN-COMPUTER INTERACTION, PT II: NOVEL INTERACTION METHODS AND TECHNIQUES, 2009, 5611 : 444 - +
  • [50] What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling
    Willy, ME
    Li, ZL
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (04) : 201 - 206